Fig. 4: Treatment responses.
Waterfall plots of the best percentage changes for the sum of target lesion diameters are shown for individual participants with platinum-refractory or resistant recurrent OC assessed by BIRC per RECIST (v.1.1). Number of participants: 281 and 140 in the suvemcitug and placebo arms, respectively. The lower dashed line indicates a 30% reduction and the upper dashed line represents a 20% increase in the target lesion size. The ORR was defined as the proportion of participants in the full analysis set with a complete response or a partial response.
